Skip to content
T. Rowe Price Institutional Events

Events and Webinars

On-demand Webinars

Asset Allocation Viewpoints: Rally On or Running Out of Steam?

After a strong equity market rally fueled by artificial intelligence (AI), investors are asking: Can the momentum carry into 2026, or will it get challenged? And importantly, where are other areas of opportunities beyond AI?
View

Tech Tour 2026: AI is Here and Now

Join T. Rowe Price for our annual Tech Tour webinar, where we unveil insights from our end-of year investment research tour of Silicon Valley.

View

Asset Allocation Viewpoints: Balancing Act

Markets stand at a pivotal crossroads, where robust earnings and the promise of artificial intelligence-driven productivity balance the headwinds of a slowing economy and stretched valuations—all under the watchful eye of an accommodative Fed.

View

Materials with Shinwoo Kim

We invite you to join us for The Analyst Spotlight, a quarterly webinar series that allows you to hear directly from the experts behind our Structured Research Equity strategies, offered in the U.S. and Canada as US Equity Research.

View

US Growth Stock Strategy Update

Join us for a timely strategy update with our US Growth Stock Strategy Team. Newly appointed Lead Portfolio Manager Jim Stillwagon will be joined by Portfolio Specialist Craig Watson and Associate Portfolio Manager Eric DeVilbiss.

View

US Mid-Cap Growth Equity Strategy Update

Join us for a timely update with our US Mid-Cap Growth Equity Strategy team. Incoming Lead Portfolio Manager Ashley Woodruff will be joined by Co-portfolio Manager Don Easley and Portfolio Specialist Brian Dausch. 

View

Impact of High Sovereign Debt on Bond Markets

Join us for the latest edition of our bi-annual webinar series ‘Ahead of the Curve’, where we will explore the intricate interplay between global bond markets, fiscal policies and economic planning. This sovereign debt centered webinar will analyse how bond markets function as potent catalysts in shaping financial strategies, and the opportunities and risks this presents to investors.

View

Biotech Frontiers: The Next Wave of Innovation

Biotech stocks have struggled as a group, but the pace of drug discovery is accelerating. In this episode of “The Angle,” Sal Rais joins Jennifer Martin to explore how new ways of treating disease are improving human health and how breakthrough drugs can create value for some biotech innovators.

View

202512-4975764

Download

Latest Date Range
Audience for the document: Share Class: Language of the document:
Download Cancel

Open

Share Class: Language of the document:
Open Cancel
Sign in to manage subscriptions for products, insights and email updates.
Sign in
Once registered, you'll be able to start subscribing.

Change Details

If you need to change your email address please contact us.
Subscriptions
OK
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price (“TRP”) claims compliance with the Global Investment Performance Standards (GIPS®).

A complete list and description of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest